MedPath
HSA Approval

LATANOPROST TOA OPHTHALMIC SOLUTION 0.005% W/V

SIN15884P

LATANOPROST TOA OPHTHALMIC SOLUTION 0.005% W/V

LATANOPROST TOA OPHTHALMIC SOLUTION 0.005% W/V

February 18, 2020

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SOLUTION, STERILE

OPHTHALMIC

Medical Information

S01EE01

latanoprost

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

Nitto Medic Co., Ltd.

Active Ingredients

Latanoprost

0.005% w/v

Latanoprost

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LATANOPROST TOA OPHTHALMIC SOLUTION 0.005% W/V - HSA Approval | MedPath